MOTS-C 10mg Peptide | Third-Party Tested | RemedyX Labs
Order MOTS-C 10mg research peptide online from RemedyX Labs. Verified batch COAs confirm purity and identity. Secure checkout, competitive pricing, and fast shipping.
MOTS-C is a mitochondrial-derived peptide encoded within mitochondrial DNA, studied in controlled laboratory models of mitochondrial signaling, cellular stress response, and metabolic pathway research. Every batch is independently tested by a third-party laboratory to confirm identity and purity, with batch-specific Certificates of Analysis (COA) available for full transparency. For laboratory research use only. Not for human or animal use. Not intended for diagnostic, therapeutic, clinical, or commercial use.
- Price: 45.00 USD
- In stock
- Purity: 99%+
- CAS Number: 1627580-64-6
- Molecular Formula: C101H152N28O22S2
- Molecular Weight: 2174.6
- Specification: 10mg/vial
- Contents: Lyophilized Powder
- Appearance: White to Off-White
- Intended Use: Research Only
- SKU: RXL-SKU-0022
Cited Research
MOTS-c: A Promising Mitochondrial-Derived Peptide for Therapeutic Exploitation
This review evaluates the potential of the mitochondrial-derived peptide MOTS-c for future experimental and therapeutic applications.
PubMed
MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis
Researchers studied MOTS-c as an exercise-induced mitochondrial regulator involved in maintaining muscle homeostasis and mitigating age-related physical decline.
PubMed, 2021
MOTS-c increases in skeletal muscle following long-term physical activity and improves acute exercise performance after a single dose
The study observed changes in skeletal muscle MOTS-c levels following long-term physical activity and its impact on acute exercise performance.
PubMed, 2022
The mitochondrial-derived peptide MOTS-c is a regulator of plasma metabolites and enhances insulin sensitivity
This research identified MOTS-c as a mitochondrial-derived peptide that regulates plasma metabolites and improves insulin sensitivity.
PubMed, 2019
Plasma MOTS-c levels are associated with insulin sensitivity in lean but not in obese individuals
The study compared associations between plasma MOTS-c levels and insulin sensitivity in lean versus obese human cohorts.
PubMed, 2018
MOTS-c peptide regulates adipose homeostasis to prevent ovariectomy-induced metabolic dysfunction
Researchers investigated the role of the MOTS-c peptide in regulating adipose homeostasis to prevent metabolic dysfunction following ovariectomy.
PubMed, 2019
Mitochondrial-Derived Peptide MOTS-c Increases Adipose Thermogenic Activation to Promote Cold Adaptation
The study examined whether the mitochondrial-derived peptide MOTS-c promotes cold adaptation by increasing thermogenic activation in adipose tissue.
PubMed, 2019
Peripheral Administration of a Cell-Penetrating MOTS-c Analogue Enhances Memory and Attenuates Aβ1–42- or LPS-Induced Memory Impairment through Inhibiting Neuroinflammation
Researchers tested whether a cell-penetrating MOTS-c analogue enhances memory and inhibits neuroinflammation in models of memory impairment.
PubMed, 2021
MOTS-c peptide increases survival and decreases bacterial load in mice infected with MRSA
The study evaluated the effects of MOTS-c on survival rates and bacterial load in mice infected with methicillin-resistant Staphylococcus aureus (MRSA).
PubMed, 2017
Mitochondrial-derived microprotein MOTS-c attenuates immobilization-induced skeletal muscle atrophy by suppressing lipid infiltration
This research explored how the mitochondrial-derived microprotein MOTS-c reduces immobilization-induced skeletal muscle atrophy by suppressing lipid infiltration.
PubMed, 2024
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance
Reports protection against diet- and age-associated metabolic dysfunction in mice.
PubMed, 2015
MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline
Links MOTS-c with exercise responses and improved physical performance in mice.
PubMed, 2021
MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation
Reviews metabolic and inflammatory research while noting translational limitations.
PubMed, 2023
MOTS-c, the Most Recent Mitochondrial Derived Peptide in Human Aging and Age-Related Diseases
Reviews MOTS-c biology in aging and age-related disease models.
PMC, 2022
Increased expression of the mitochondrial derived peptide MOTS-c in skeletal muscle of healthy aging men
Examines circulating and skeletal-muscle MOTS-c across age groups.
PubMed, 2020
Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging
Reviews AMPK-related signaling and metabolic effects.
PubMed, 2023
Mitochondrial-Encoded Peptide MOTS-c, Diabetes, and Aging-Related Diseases
Summarizes diabetes-focused evidence and research gaps.
PubMed, 2023
MOTS-c modulates skeletal muscle function by directly regulating CK2 activity
Reports a CK2-linked mechanism affecting muscle mass and glucose uptake.
PMC, 2024
MOTS-c Serum Concentration Positively Correlates with Muscle Mass and Power
Reports associations between serum MOTS-c and measures of muscle mass and power.
PMC, 2023